{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:30:52Z","timestamp":1791311452195,"version":"4.3.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI CA23766"],"award-info":[{"award-number":["NCI CA23766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI R21CA162002"],"award-info":[{"award-number":["NCI R21CA162002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Family Fund for Cancer Research"},{"name":"Max Cure Fund for Pediatric Cancer Research"},{"name":"Aubrey Fund for Pediatric Cancer Research"},{"name":"Claire Tow Chair in Pediatric Oncology Research"},{"name":"ASCO Foundation"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbmt.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T03:38:31Z","timestamp":1432870711000},"page":"1663-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia"],"prefix":"10.1016","volume":"21","author":[{"given":"Guenther","family":"Koehne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Doubrovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-5728","authenticated-orcid":false,"given":"Susan","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.05.015_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib2","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","article-title":"Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation","volume":"102","author":"Hakki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/517301","article-title":"Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma","volume":"176","author":"Zaia","year":"1997","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2015.05.015_bib4","first-page":"S72","article-title":"Immune reconstitution and viral infections after stem cell transplantation","volume":"21","author":"Ljungman","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib5","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","article-title":"The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy","volume":"103","author":"Boeckh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198207013070102","article-title":"Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients","volume":"307","author":"Quinnan","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.05.015_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2141.2005.05800.x","volume":"131","author":"Ohnishi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591185","article-title":"Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"198","author":"Moins-Teisserenc","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.05.015_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbmt.2010.02.007","article-title":"Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Luo","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1705507","article-title":"Impact on the cytomegalovirus (CMV) viral load by CMV-specific T cell immunity in recipients of allogeneic stem cell transplantation","volume":"38","author":"Avetisyan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/bmt.2008.403","article-title":"Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT","volume":"43","author":"Pourgheysari","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib13","doi-asserted-by":"crossref","first-page":"e3634","DOI":"10.1371\/journal.pone.0003634","article-title":"Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation","volume":"3","author":"Widmann","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2015.05.015_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbmt.2003.12.004","article-title":"Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants","volume":"10","author":"Lacey","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2015.05.015_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.05.015_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.05.015_bib18","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex\u00a0vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib20","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib21","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2003-05-1433","article-title":"Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy","volume":"105","author":"Trivedi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib22","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.0804178","article-title":"A\u00a0panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy","volume":"183","author":"Hasan","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1182\/blood.V99.5.1730","article-title":"Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors","volume":"99","author":"Koehne","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib24","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood-2011-11-394619","article-title":"Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias","volume":"120","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI119338","article-title":"Determination of antigen-specific memory\/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency","volume":"99","author":"Waldrop","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bbmt.2015.05.015_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00163961","article-title":"The extent of the human germline T cell receptor V beta gene segment repertoire","volume":"40","author":"Wei","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2015.05.015_bib27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib28","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1128\/jcm.34.5.1337-1339.1996","article-title":"Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence","volume":"34","author":"Landry","year":"1996","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jmv.1890390207","article-title":"Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease","volume":"39","author":"Ehrnst","year":"1993","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1386-6532(01)00240-2","article-title":"Rapid detection and quantification of CMV DNA in urine using LightCycler-based real-time PCR","volume":"24","author":"Kearns","year":"2002","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jviromet.2007.01.033","article-title":"Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients","volume":"143","author":"Mhiri","year":"2007","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.bbmt.2015.05.015_bib32","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/jvi.70.11.7569-7579.1996","article-title":"The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T cell receptor usage of pp65-specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/viro.1996.0424","article-title":"Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells","volume":"222","author":"Boppana","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.bbmt.2015.05.015_bib34","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.178.7.4455","article-title":"T\u00a0cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection","volume":"178","author":"Khan","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib35","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.4049\/jimmunol.1302281","article-title":"CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity","volume":"192","author":"Ameres","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib36","first-page":"91","article-title":"Modulation of HLA expression in human cytomegalovirus immune evasion","volume":"4","author":"Lin","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bmt.1704232","article-title":"Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Yanada","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1703648","article-title":"High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation","volume":"30","author":"Nakamura","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.05.015_bib39","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"issue":"Supplement 2","key":"10.1016\/j.bbmt.2015.05.015_bib40","first-page":"S220","article-title":"Adoptive transfer of EBV-specific T cells for treatment of primary and rituxan-resistant EBV lymphomas following allogeneic stem cell transplants (HSCT): clinical, viral and immunologic correlates","volume":"16","author":"Doubrovina","year":"2010","journal-title":"BBSMT"},{"key":"10.1016\/j.bbmt.2015.05.015_bib41","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2015.05.015_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","article-title":"Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells","volume":"360","author":"Haque","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.05.015_bib44","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib45","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib46","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T cell-depleted stem cell transplantation","volume":"95","author":"Broers","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V97.4.835","article-title":"An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs","volume":"97","author":"Gottschalk","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib48","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JVI.75.5.2472-2474.2001","article-title":"Infrequent occurrence of natural mutations in the pp65(495-503) epitope sequence presented by the HLA A*0201 allele among human cytomegalovirus isolates","volume":"75","author":"Zaia","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib49","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1128\/jvi.69.8.4830-4841.1995","article-title":"Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains","volume":"69","author":"Jones","year":"1995","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib50","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1073\/pnas.93.20.10990","article-title":"Human cytomegalovirus inhibits antigen presentation by a sequential multistep process","volume":"93","author":"Ahn","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2015.05.015_bib51","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ni.2097","article-title":"Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1","volume":"12","author":"Kim","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib52","first-page":"293","article-title":"Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections","volume":"35","author":"Bao","year":"2012","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.bbmt.2015.05.015_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2015.05.015_bib54","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2015.05.015_bib55","doi-asserted-by":"crossref","first-page":"242ra283","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2015.05.015_bib56","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2013-03-487249","article-title":"Pharmacotherapy versus T lymphocytes for CMV","volume":"121","author":"Heslop","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib57","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/340637","article-title":"Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals","volume":"185","author":"Kern","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.05.015_bib58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0198-8859(03)00028-4","article-title":"Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles","volume":"64","author":"Lacey","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib59","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.05.015_bib60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2015.05.015_bib61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","article-title":"Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation","volume":"51","author":"Schmitt","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2015.05.015_bib62","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2015.05.015_bib63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.2009.07969.x","article-title":"Cytomegalovirus-specific CD8(+) T cells targeting different HLA\/peptide combinations correlate with protection but at different threshold frequencies","volume":"148","author":"Giest","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.05.015_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.V124.21.184.184","article-title":"Third-party donor derived CMV specific T cells for the treatment of refractory CMV viremia and disease after hematopoietic stem cell transplant. [ASH Meeting Abstracts]","volume":"124","author":"Prockop","year":"2014","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115003729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115003729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:07Z","timestamp":1761058267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115003729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1083879115003729"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.05.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}